Evidence map›Paper›PMID 27366155›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2016

Outbreak of Norovirus GII.P17-GII.17 in the Canadian Province of Nova Scotia.

Jason J LeBlanc, Janice Pettipas, Daniel Gaston, Robin Taylor, Todd F Hatchette, Tim F Booth, Russell Mandes, Andrew McDermid, Elsie Grudeski

Open access · goldAbstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jason J LeBlancNova Scotia Health Authority (NSHA), Halifax, NS, Canada B3H 1V8; Dalhousie University, Halifax, NS, Canada B3H 4R2.
Janice PettipasNova Scotia Health Authority (NSHA), Halifax, NS, Canada B3H 1V8; Provincial Public Health Laboratory Network of Nova Scotia (PPHLN), Halifax, NS, Canada B3H 1V8.
Daniel GastonNova Scotia Health Authority (NSHA), Halifax, NS, Canada B3H 1V8; Dalhousie University, Halifax, NS, Canada B3H 4R2.
Robin TaylorNova Scotia Health Authority (NSHA), Halifax, NS, Canada B3H 1V8; Dalhousie University, Halifax, NS, Canada B3H 4R2.
Todd F HatchetteNova Scotia Health Authority (NSHA), Halifax, NS, Canada B3H 1V8; Dalhousie University, Halifax, NS, Canada B3H 4R2.
Tim F BoothNational Microbiology Laboratory (NML), Winnipeg, MB, Canada R3E 3R2; University of Manitoba, Winnipeg, MB, Canada R3T 2N2.
Russell MandesNational Microbiology Laboratory (NML), Winnipeg, MB, Canada R3E 3R2.
Andrew McDermidUniversity of Manitoba, Winnipeg, MB, Canada R3T 2N2.
Elsie GrudeskiNational Microbiology Laboratory (NML), Winnipeg, MB, Canada R3E 3R2.
Nova Scotia Health Authority · CAUniversity of Manitoba · CADalhousie University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Norovirus is the leading cause of viral gastroenteritis, with GII.4 being the most common circulating genotype. Recently, outbreaks in China revealed that norovirus GII.17 GII.P17 had become predominant. Objective. This study aimed to characterize the distribution of norovirus genotypes circulating in Nova Scotia. Methods. Stool specimens were collected from gastrointestinal outbreaks in Nova Scotia between Jan 2014 and June 2015 and subjected to real-time RT-PCR. Norovirus-positive specimens were referred to the National Microbiology Laboratory for sequence-based genotyping. Results. The first norovirus GII.P17-GII.17 outbreak in Canada was identified, but no widespread activity was observed in Nova Scotia. Discussion. It is unknown whether GII.P17-GII.17 is more widespread in Canada since contributions to Canadian surveillance are too sparse to effectively monitor the epidemiology of emerging norovirus genotypes. Conclusions. Presence of norovirus GII.17:P17 in Canada highlights the need for more systematic surveillance to ensure that molecular targets used for laboratory detection are effective and help understand norovirus evolution, epidemiology, and pathogenesis.

Identifiers

PMID27366155
PMCPMC4904589
OpenAlexW2343358515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.